PRESS DIGEST-Financial Times - Jan 19 · 3h ago
Smith & Howard Wealth Management, LLC Buys iShares National Muni Bond ETF, Vanguard ...
Atlanta, GA, based Investment company Smith & Howard Wealth Management, LLC (Current Portfolio) buys iShares National Muni Bond ETF, Vanguard Short-Term Government Bond ETF, ISHARES TRUST, iShares Short-Term National Muni Bond ETF, Vanguard Large Cap ETF, ... · 6h ago
Vaccine’s Rocky Journey in Philippines Shows Why Fast End to Covid Is Threatened
(Bloomberg) -- After losing her son to Covid-19 last year, 79-year-old Tomasa Valdez was desperate to get vaccinated. But on the remote Philippine island of San Salvador, where she lives, there were no shots to be had. Most Read from BloombergMicrosoft Buy...
Bloomberg · 7h ago
Why You Should Invest in Dividend Growth ETFs Now
We highlight 3 ultra-cheap ETFs that focus on high quality dividend payers
Zacks · 9h ago
Pfizer says lab studies indicate COVID antiviral Paxlovid effective against Omicron
Pfizer (PFE -2.3%) says that several lab studies it has conducted indicate that its COVID-19 antiviral pill Paxlovid (nirmatrelvir [PF-07321332] tablets and ritonavir) is effective against the Omicron variant. The
Seekingalpha · 10h ago
Unilever’s bid for consumer unit unlikely to generate upside for GlaxoSmithKline - BofA
Unilever (NYSE:UL) has approached a 52-week low as Wall Street weighs in on its setback to acquire the consumer arm of GlaxoSmithKline (NYSE:GSK), partly owned by Pfizer (NYSE:PFE). Over the
Seekingalpha · 10h ago
Why Moderna, Pfizer, BioNTech And Novavax Shares Are Falling Today
Shares of vaccine makers, including Moderna Inc (NASDAQ: MRNA), BioNTech SE - ADR (NASDAQ: BNTX) and Novavax, Inc.
Benzinga · 12h ago
This New Study Suggests Pfizer, BioNTech Are Losing The Omicron Battle
A fourth dose of Pfizer and BioNTech's Covid shot is only partly effective against omicron, according to a new test. The vaccine stocks fell.
Investor's Business Daily · 12h ago
Africa Hopes to Secure Pfizer’s Covid Pill in the Coming Weeks
Bloomberg · 12h ago
Omicron cases seem to have peaked in northeastern states, but national case tally is still at record levels and hospitals are slammed
Signs that the omicron-driven surge of coronavirus cases may be peaking in northeastern states where it took hold earliest weighed against continued stress on hospitals on Tuesday, as the national case rate stood at a record of about 800,000 a day. · 12h ago
AstraZeneca (AZN) Enhertu sBLA Receives FDA Priority Tag
AstraZeneca's (AZN) sBLA seeks approval of Enhertu for unresectable and/or metastatic HER2-positive metastatic breast cancer previously treated with an anti-HER2-based regimen.
Zacks · 13h ago
Sema4 Strengthens AI-Driven Genomic, Clinical Data Platform With $623M GeneDx Acquisition
Sema4 Holdings Corp (NASDAQ: SMFR) has 
Benzinga · 13h ago
Ayalon Holdings Ltd. Buys iShares Russell 2000 ETF, Invesco S&P 500 High Beta ETF, JPMorgan ...
Investment company Ayalon Holdings Ltd. (Current Portfolio) buys iShares Russell 2000 ETF, Invesco S&P 500 High Beta ETF, JPMorgan U.S. · 14h ago
IFM Investors Pty Ltd Buys Pfizer Inc, Salesforce. ...
Investment company IFM Investors Pty Ltd (Current Portfolio) buys Pfizer Inc, Inc, PepsiCo Inc, Texas Instruments Inc, Charles Schwab Corp, sells , Autoliv Inc, Apollo Global Management Inc, Lamb Weston Holdings Inc, during the 3-months ende... · 14h ago
Unilever plunges as investors react to its bid for GlaxoSmithKline’s consumer unit
With a decline of ~9.3%, Unilever (NYSE:UL) ADRs are trading sharply lower in the -market after the company confirmed its proposed acquisition of GlaxoSmithKline’s (NYSE:GSK) consumer unit. In an update issued
Seekingalpha · 14h ago
Too Early to Tell if Pfizer Job Cuts Tied to More Virtual Meetings Will Be a Trend
Pfizer’s long-term virtual meetings push has not come as a shock to the corporate travel sector — experts have said it could be unique to the pharmaceutical sector, rather signaling a major shift in the way organizations conduct business. The vaccine maker...
Skift · 15h ago
5 Low-Beta High-Yielding Stocks to Buy in a Capricious Market
We have narrowed our search to five large-cap low-beta stocks with a solid dividend yield. These are: PFE, BAX, IBKR, PSA and CUBE.
Zacks · 16h ago
Zacks Industry Outlook Highlights: Roche, Pfizer, AbbVie and Merck
Roche, Pfizer, AbbVie and Merck are highlighted in this Industry Outlook article.
Zacks · 16h ago
Pfizer To Boost Output For COVID-19 Oral Treatment With Novasep Deal
Benzinga · 17h ago
FDA Gives Back To Back Approval To Pfizer's & AbbVie's JAK Inhibitors For Atopic Dermatitis
Along with AbbVie Inc's (NYSE: ABBV) 
Benzinga · 17h ago
Webull provides a variety of real-time PFE stock news. You can receive the latest news about Pfizer through multiple platforms. This information may help you make smarter investment decisions.
About PFE
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.